Hereditary Breast Cancer

Understanding the Types of Hereditary Breast Cancer

While the majority of breast cancer cases are "sporadic", meaning they happen by chance or due to a mix of lifestyle and aging, about 5% to 10% are hereditary.

Hereditary breast cancer occurs when a person is born with an inherited gene mutation passed down from their mother or father.

In the past, medical science only focused on a couple of specific genetic links. Today, genetic specialists look at an expanded panel of genes. Doctors categorize these genes based on their penetrance, which simply describes how likely a person with that specific mutation is to develop cancer in their lifetime.

High-Penetrance Genes: The Major Risk Factors

High-penetrance genes carry the highest lifetime risk of developing breast cancer, often above 50%. This means that from two persons carrying such a mutation, one will develop breast cancer during their lifetime.

The most widely studied and well-known hereditary gene variants are:

BRCA1 and BRCA2

BRCA1 (BReast CAncer 1) and BRCA2 (BReast CAncer 2) genes are responsible for Hereditary Breast and Ovarian Cancer (HBOC) syndrome.

Why? Think of BRCA1 and BRCA2 genes as the body’s automatic spell-checkers or mechanics for your DNA, your genetic code within every body cell.

How they normally work: Every day, your cells divide and copy their DNA. Sometimes, typos or mistakes happen. Normal BRCA genes act like spell-checkers, they spot the errors, fix them, and keep the cells growing safely. Because they prevent bad cells from turning into tumors, they are called tumor suppressors.

What happens when they mutate: If a person inherits a "mutated" (broken) version of these genes, the spell-checker doesn't work. The DNA mistakes don't get fixed. Over time, these uncorrected mistakes pile up, which drastically increases the chances of cells growing out of control and turning into breast or ovarian cancer.

Other risks: Because these spell-checker genes protect cells throughout the whole body, a glitch in them also raises the risk for a few other cancers, specifically pancreatic and prostate cancers.

PALB2

Often referred to as the Partner And Localizer of BRCA2, PALB2 is a critical high-penetrance gene.

The Helper Molecule: If BRCA2 is a master mechanic fixing typos in your DNA, PALB2 is the mechanic’s essential toolkit or partner. Its exact job is to guide the BRCA2 protein to the precise spot where the DNA is broken so it can be fixed. [1] (https://www.bcrf.org/about-breast-cancer/what-is-palb2/

What happens during a mutation: If the PALB2 gene is "mutated" (broken), the mechanic (BRCA2) loses its tools and doesn't know where to go. The DNA damage is left unrepaired, causing dangerous errors to stack up.

The Breast Cancer Risk: Because the body loses this crucial line of defense, a woman carrying this mutation faces over 50% chance of developing breast cancer in her lifetime.

Other Risks: Just like the BRCA genes, a faulty PALB2 gene also moderately elevates the risk for ovarian, pancreatic, and prostate cancers because the entire body's DNA repair network is weakened.

TP53 (Li-Fraumeni Syndrome)

A rare but high-risk mutation can occur in the TP53 (Tumor Protein 53) and cause Li-Fraumeni syndrome, a condition that severely predisposes individuals to very early-onset breast cancer, alongside sarcomas and brain tumors.

The Ultimate Gatekeeper: In a healthy body, the TP53 gene monitors cell growth. If a cell becomes damaged or starts growing abnormally, TP53 steps in and acts as a security guard: it either forces the cell to pause and fix its DNA, or, if the damage is too severe, it orders the cell to self-destruct so it can't turn into cancer.

What happens during a mutation: When a person has a mutated (broken) TP53 gene, they develop a rare condition called Li-Fraumeni syndrome. Without this critical security guard on duty, damaged and malfunctioning cells are allowed to freely divide, multiply, and grow out of control.

The Cancer Risks: Because TP53 is the main defense system for the entire body, a glitch here drastically increases the risk of developing several different types of cancer, often at a very young age (even during childhood or young adulthood). These include Early-onset breast cancer, Sarcomas (cancers that start in the bones or muscles), Brain tumors, Leukemia, and adrenal gland tumors.

PTEN (Cowden Syndrome)

A mutation in the PTEN (Phosphatase and Tensin homolog deleted on chromosome 10) gene causes Cowden syndrome, which leads to a 25 to 50% lifetime breast cancer risk.

Building on the security analogies we used earlier, you can think of the PTEN gene as the body’s ultimate cellular brake pedal.

The Brake Pedal: In a healthy body, cells receive chemical signals telling them to eat, grow, and divide. PTEN sits on the main control pathway and acts as the brakes. When cells have grown enough, PTEN steps in to cut off the growth signals so the cells stop dividing.

What happens during a mutation: According to the PTEN Foundation, if a person inherits a mutated (broken) PTEN gene, the body loses its cellular brakes. The growth signals stay turned "on" permanently, causing cells to divide rapidly and continuously.

The Related Condition: An inherited mutation in this gene causes a condition known as PTEN Hamartoma Tumor Syndrome (PHTS), which is also commonly called Cowden syndrome.

The Cancer Risks: Because the cell growth signals can't be turned off, individuals with this mutation have a significantly higher lifetime risk of developing benign (non-cancerous) growths called hamartomas, as well as specific cancers. These primarily include Breast cancer, Thyroid cancer, Uterine (endometrial) cancer, Kidney cancer, and Colorectal cancers.

CDH1 Gene

You can think of the CDH1 (Cadherin 1) gene as the body’s master architect responsible for making cellular glue.

The Cellular Glue: In a healthy body, tissues need to stay tightly organized. The CDH1 gene produces a "glue" protein that securely fastens neighboring cells to one another. This keeps your stomach lining and breast tissues structured and prevents individual cells from breaking away and wandering off. Because it stops rogue cells from drifting away and multiplying elsewhere, it functions as a critical tumor suppressor.

What happens during a mutation: If a person inherits a mutated (broken) CDH1 gene, their body lacks this cellular glue. Because the cells cannot stick together properly, they lose their structural boundaries. If a cancer cell develops, it doesn't form a tight, easily noticeable lump. Instead, it spreads out silently in scattered, single-file lines.

The Cancer Risks: Because this specific "glue" is most active in the stomach and the milk lobes of the breast, a mutation heavily spikes the risk for two very specific cancers according to the National Comprehensive Cancer Network (NCCN) Guidelines:

Diffuse Stomach Cancer: A highly aggressive stomach cancer where tumor cells grow in a scattered pattern right under the stomach lining, making it incredibly difficult to spot early on with a standard endoscopy.
Lobular Breast Cancer: A type of breast cancer that affects the milk-producing glands (Memorial Sloan Kettering Cancer Center). Unlike common breast cancers, it often grows in thin strands rather than a hard lump, meaning it can easily hide from traditional mammograms and usually requires an annual breast MRI for screening.

Moderate-Penetrance Genes: The Multipliers

Moderate-penetrance genes do not carry quite as high a risk as BRCA, but they still significantly multiply a person's chances of developing breast cancer compared to the general population.

CHEK2

This gene produces a checkpoint kinase that helps the cell halt division if DNA is damaged.

You can think of the CHEK2 gene as a factory quality control inspector on a fast-moving assembly line.

How it normally works: As your cells continuously divide to create new cells, CHEK2 stands watch. If it notices a defect or "typo" in a cell's DNA, it pulls a giant emergency lever to halt division immediately. This freeze-frame gives the cell time to fix its DNA before it replicates.

What happens during a mutation: If you inherit a mutated version, such as the common CHEK2 1100delC variant mentioned in the image, the quality control inspector is missing. Damaged cells bypass the checkpoint and keep dividing anyway.

The Cancer Risks: Missing this checkpoint generally doubles or triples a woman's lifetime risk of breast cancer. The image notes it is specifically linked to the estrogen receptor-positive (ER+) subtype, meaning the resulting cancer cells use the hormone estrogen to grow. It also moderately increases the risk for colon and prostate cancers.

ATM

You can think of the ATM gene as the body’s cellular emergency services dispatcher.

How it normally works: DNA strands inside your cells are fragile and can suffer severe structural breaks (like snapped telephone wires). The ATM gene constantly monitors the cell. The moment a critical break happens, ATM instantly sounds the alarm and coordinates the "first responders" (other proteins like BRCA1 and TP53) to rush to the scene and weld the broken strands back together.

What happens during a mutation: When the ATM gene is mutated, the emergency alarm system is broken. Severe DNA damage occurs, but no emergency signals are sent out. The cell continues to grow blindly with completely broken blueprints.

The Cancer Risks: Because the body's primary alarm system for severe DNA breaks is offline, mutations in the ATM gene roughly double the average lifetime risk of breast cancer. It is also associated with an elevated risk for pancreatic cancer.

High-Penetrance vs. Moderate-Penetrance At a Glance

Gene Group	Core Genes Involved	Estimated Lifetime Breast Cancer Risk	Associated Secondary Cancer Risks
High Penetrance	BRCA1, BRCA2, PALB2, TP53, PTEN, CDH1	50% to 85%	Ovarian, Pancreatic, Prostate, Stomach, Thyroid
Moderate Penetrance	CHEK2, ATM, BRIP1, RAD51C	20% to 40%	Colon, Ovarian, Prostate

Who Should Consider Genetic Testing?

Because genetic traits affect entire families, understanding your roots is crucial. Major medical guidelines, including the American Society of Breast Surgeons Consensus, ASCO Germline Testing Guidelines, European Society for Medical Oncology (ESMO), and the European Commission Initiative on Breast Cancer (ECIBC), among other, outline red flags that suggest a cancer pattern in a family.

You should consider speaking to a genetic counselor if your family history includes:

A relative diagnosed with breast cancer at age 50 or younger.
A history of triple-negative breast cancer or male breast cancer within the same bloodline.
Having a known blood line family member with a BRCA mutation
The presence of both breast and ovarian cancer within the same bloodline.
Multiple relatives on the same side of the family diagnosed with breast, ovarian, pancreatic, or advanced prostate cancers.

Knowledge is Prevention

Finding out you have a genetic mutation can feel incredibly overwhelming. However, as clinical genetics experts note, this knowledge is power. Identifying a mutation early gives you and your doctor a roadmap. It unlocks specialized, proactive screening strategies, such as annual breast MRIs beginning earlier at age, long before standard screening guidelines would normally apply to the general public.

TheKnowHow Independent Second Opinion Service

Are you or a loved one have been diagnosed with breast cancer? You are overwhelmed or unsure about your diagnosis or planned treatment?

TheKnowHow Independent Second Opinion Service is not intended to take you away from your treating doctor but rather provide an extra level of competence.

Get an unbiased assessment from an international expert without having to travel or schedule appointments. Our impartial specialists conduct a record-based assessment of your current health state and all available treatment options, including their advantages and potential hazards.

DISCLAIMER: This information is for general knowledge, should not be taken as medical advice, and you should consult with a healthcare provider if you have health issues.